2021
Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review
Nalven T, Spillane N, Schick M, Weyandt L. Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review. Experimental And Clinical Psychopharmacology 2021, 29: 524-538. PMID: 34242040, PMCID: PMC8511246, DOI: 10.1037/pha0000510.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesics, OpioidBuprenorphineHumansMethadoneNaltrexoneOpioid-Related DisordersUnited StatesConceptsOpioid use disorderPharmacological treatmentPharmacological treatment trialsTreatment trialsRandomized controlled trialsLack of subgroup analysesDiverse sampleMultiracial individualsNative Hawaiian/Other Pacific IslanderAmerican Indian/Alaska Native (AI/ANMedication typeSystematic reviewPharmacological careMarginalized backgroundsRandomized clinical trialsPreferred Reporting ItemsBlack individualsOpioidSex/genderSES indicatorsNaltrexoneSubgroup analysisClinical trialsReporting ItemsIncreased risk
2019
Risk and protective factors for opioid misuse in American Indian adolescents
Nalven T, Spillane N, Schick M. Risk and protective factors for opioid misuse in American Indian adolescents. Drug And Alcohol Dependence 2019, 206: 107736. PMID: 31765857, PMCID: PMC6980750, DOI: 10.1016/j.drugalcdep.2019.107736.Peer-Reviewed Original ResearchConceptsOpioid misusePeer substance useAssociated with greater likelihoodSubstance useMonth heroin useGreater likelihoodAI adolescentsLifetime heroinOpioid useOpioidSelf-report questionnairesRisk factorsAI youthHeroin useSchool-based samplePast-monthLow school performanceLogistic regressionFamily disapprovalSchool-related factorsInfluence of peersMultilevel logistic regressionHeroinMonthsSchool performance